Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study

BACKGROUND: Polycystic ovarian syndrome (PCOS) is a highly variable syndrome and one of the most common female endocrine disorders. Although the association inositols-glucomannan may represent a good therapeutic strategy in the treatment of PCOS women with insulin resistance, the effect of inositols...

Descripción completa

Detalles Bibliográficos
Autores principales: Troisi, Jacopo, Cinque, Claudia, Giugliano, Luigi, Symes, Steven, Richards, Sean, Adair, David, Cavallo, Pierpaolo, Sarno, Laura, Scala, Giovanni, Caiazza, Maria, Guida, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431025/
https://www.ncbi.nlm.nih.gov/pubmed/30904021
http://dx.doi.org/10.1186/s13048-019-0500-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431025/
https://www.ncbi.nlm.nih.gov/pubmed/30904021
http://dx.doi.org/10.1186/s13048-019-0500-x

Ejemplares similares